Susquehanna International Group’s Acura Pharmaceuticals ACUR Stock Holding History

Susquehanna International Group’s Portfolio ACUR Stock Details ACUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,052	Closed	-$10K	–	10681
2015 Q2	$10K	Buy	+2,052	New	+$8.52K	﹤0.01%	10034
2015 Q1	–	Sell	-3,346	Closed	-$8K	–	10362
2014 Q4	$8K	Buy	+3,346	New	+$9.26K	﹤0.01%	9530
2014 Q3	–	Sell	-3,385	Closed	-$18K	–	10345
2014 Q2	$18K	Buy	3,385 +333	+11%	+$2.02K	﹤0.01%	9686
2014 Q1	$22K	Sell	3,052 -559	-15%	-$4.86K	﹤0.01%	8781
2013 Q4	$30K	Sell	3,611 -2,704	-43%	-$22.8K	﹤0.01%	8867
2013 Q3	$60K	Buy	+6,315	New	+$55.8K	﹤0.01%	8198

Other funds holding ACUR

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Susquehanna International Group's ACUR Position: Q3 2015 in Review

Susquehanna International Group sold out of Acura Pharmaceuticals (ACUR) in Q3 2015, closing a stake of 2,052 shares — an estimated $10K sold.

Susquehanna International Group first reported a position in ACUR in Q3 2013 and held it in 6 quarters. The position peaked at $60K in Q3 2013. 22 funds tracked by Wall St. Rank hold ACUR as of Q3 2015.

Susquehanna International Group reported no remaining Acura Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Susquehanna International Group sold 2,052 Acura Pharmaceuticals shares in Q3 2015, an estimated $10K.
Susquehanna International Group first reported a position in Acura Pharmaceuticals in Q3 2013 and held it in 6 quarters.
Susquehanna International Group's Acura Pharmaceuticals position peaked at $60K in Q3 2013.
22 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q3 2015.

Based on Susquehanna International Group's 13F filing for Q3 2015, filed 16 Nov 2015.